Healthleap raises $38M for its AI that flags hospital patients who may need a closer look

Healthleap, a startup founded in South Africa in 2022 by siblings Jemima and Josiah Meyer, has raised $38 million in seed and Series A funding. The round includes an $8 million seed co-led by Sequoia Capital and First Round Capital, and a $30 million Series A led by Hummingbird Ventures. The company does not disclose its valuation.

Healthleap initially offered a clinical nutrition tool, then pivoted to a general-purpose AI platform that plugs into hospital electronic health records. It uses language models to extract clinical concepts from clinicians' written notes, such as poor appetite or difficulty swallowing, and combines that with structured data like labs, weights, and vital signs to produce nightly risk scores. The software does not diagnose patients; it highlights them for additional review. It is deployed in more than 50 hospitals and screens for malnutrition, delirium, aspiration pneumonia, pressure ulcers, and readmission risk for congestive heart failure.

Since pivoting, Healthleap has grown from three hospital partners to more than 50, with customers including Penn Medicine, Cedars-Sinai, Intermountain, Houston Methodist, and Emory Healthcare. Revenue has grown more than 10x over the past year. The company sells three-year contracts priced by licensed bed count and uses an outcome-based pricing model, claiming every customer has seen at least 5x hard ROI, with some exceeding 20x. At the Hospital of the University of Pennsylvania, its malnutrition program reportedly produced $23.8 million in annualized financial impact, including $6.3 million from additional reimbursement and $17.5 million from shorter stays. Healthleap plans to use the funding for engineering, product, sales, and customer success as it expands to cover more than 40 major health conditions and moves into outpatient and home care.

(Source：TechCrunch)